These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 24079361)
21. [Optimization of a floating osmotic pump system of ambroxol hydrochloride using central composite design-response surface methodology and its pharmacokinetics in Beagle dogs]. Zhao F; Ma YL; Jin XL; Wang J; Cao DY Yao Xue Xue Bao; 2011 Dec; 46(12):1507-14. PubMed ID: 22375427 [TBL] [Abstract][Full Text] [Related]
22. Extrudable core system: development of a single-layer osmotic controlled-release tablet. Waterman KC; MacDonald BC; Roy MC J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796 [TBL] [Abstract][Full Text] [Related]
23. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent. Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144 [TBL] [Abstract][Full Text] [Related]
27. Nano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent. Bahari LA; Javadzadeh Y; Jalali MB; Johari P; Nokhodchi A; Shokri J Colloids Surf B Biointerfaces; 2017 May; 153():27-33. PubMed ID: 28208062 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration. Wells SM; Glerum LE; Papich MG Am J Vet Res; 2008 Dec; 69(12):1548-54. PubMed ID: 19045999 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus. Lim GJ; Ishiuji Y; Dawn A; Harrison B; Kim DW; Atala A; Yosipovitch G Acta Derm Venereol; 2008; 88(4):327-30. PubMed ID: 18709299 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumps. Wermeling DP; Miller JL; Archer SM; Rayens MK; Rudy AC J Clin Pharmacol; 2005 Aug; 45(8):969-73. PubMed ID: 16027409 [No Abstract] [Full Text] [Related]
31. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine. Goldstein J; Gawel MJ; Winner P; Diamond S; Reich L; Davidson WJ; Sussman NM Headache; 1998; 38(7):516-22. PubMed ID: 15613167 [TBL] [Abstract][Full Text] [Related]
32. Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent. Sotthivirat S; Haslam JL; Lee PI; Rao VM; Stella VJ J Pharm Sci; 2009 Jun; 98(6):1992-2000. PubMed ID: 18823032 [TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Verma RK; Kaushal AM; Garg S Int J Pharm; 2003 Sep; 263(1-2):9-24. PubMed ID: 12954176 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus). Riggs SM; Hawkins MG; Craigmill AL; Kass PH; Stanley SD; Taylor IT Am J Vet Res; 2008 May; 69(5):596-603. PubMed ID: 18447789 [TBL] [Abstract][Full Text] [Related]
35. Inlay osmotic pump tablets containing metformin and glipizide. Patel RB; Patel GN; Patel HR; Patel MM Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414 [TBL] [Abstract][Full Text] [Related]
37. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816 [TBL] [Abstract][Full Text] [Related]
38. Design and formulation of nano-porous controlled porosity osmotic pumps (CPOPs) containing a poorly water soluble drug, glibenclamide. B LA; Javadzadeh Y; Jalali MB; Nokhodchi A; Shokri J Pak J Pharm Sci; 2019 Sep; 32(5):1979-1986. PubMed ID: 31813861 [TBL] [Abstract][Full Text] [Related]